Advertisement

Topics

Trilantic North America Company Profile

03:23 EDT 20th June 2019 | BioPortfolio

Trilantic Capital Management L.P. ("Trilantic North America") is a private equity firm focused on control and significant minority investments in North America. Trilantic North America’s primary investment focus is in the business services, consumer, and energy sectors. Trilantic North America currently manages six private equity fund families with aggregate capital commitments of $8.4 billion. For more information, visit www.trilanticnorthamerica.com.


News Articles [2931 Associated News Articles listed on BioPortfolio]

Radiological Society of North America, Nov. 25-30

The 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America The annual meeting of the Radiological Society of North America was held from Nov. 25 to 30 in Chicago and...

Across North America and the Atlantic, an enormous migration journey for a tiny songbird

(University of Massachusetts at Amherst) Blackpoll warblers that breed in western North America may migrate up to 12,400 miles roundtrip each year, some crossing the entire North American continent be...

PepsiCo announces leadership appointments

PepsiCo announced that its current chief executive officer would be retiring at the end of March

URGO Medical strengthens its position in North America by acquiring Realm Therapeutics’ assets

This acquisition reinforces URGO Medical’s innovative product portfolio and its footprint in North America. URGO Medical acquires a worldwide proprietary innovative technology to strengthen posi...

The North America aluminum market accounted for $12,076. ...

NEW YORK, Jan. 10, 2019 /PRNewswire/ -- North America Aluminum Market by Processing Method (Flat Rolled, Castings, Extrusions, Forgings, Pigments & Powders, and Rod & Read more...

Healthcare Providers in North America [Report Updated: 07052019] Prices from USD $350

Healthcare Providers in North AmericaSummaryHealthcare Providers in North America industry profile provides topline qualitative and quantitative summary information including: market size value 201418...

North America Leads Pharma Sales Outlook

North America should continue to lead global pharmaceutical sales up to 2022, with $635 billion in revenue expected that year, drugmaker AstraZeneca said in a recently published outlook on the industr...

'Revealing Greater Cahokia' details research on ancient North American metropolis

(University of Illinois at Urbana-Champaign) A new book, 'Revealing Greater Cahokia, North America's First Native City,' offers the most complete picture yet of a decade of archaeological research on ...

PubMed Articles [1093 Associated PubMed Articles listed on BioPortfolio]

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.

Cefiderocol (S-649266) is a parenteral siderophore cephalosporin currently in Phase III of clinical development. In this study, we determined the in vitro susceptibility of a 2015-2016 collection of 8...

Differences in the imaging of Crohn's disease patients between North America and Europe: are we ready to bridge the divide?

The emphasis of treatment in Crohn's disease has evolved from a reactive model to "treat-to-target" approaches. Cross-sectional imaging has rapidly evolved in parallel, with a growing evidence base su...

The Incidence and Outcomes of Surgical Pulmonary Embolectomy in North America.

There has been renewed interest in surgical pulmonary embolectomy (SPE) for the treatment of pulmonary embolism, but the real-world incidence and outcomes of SPE have yet to be well described using a ...

Tackling the Radiological Society of North America Pneumonia Detection Challenge.

We provide overviews of deep learning approaches used by two top-placing teams for the 2018 Radiological Society of North America (RSNA) Pneumonia Detection Challenge. Practical applications of deep ...

Migration corridors of adult Golden Eagles originating in northwestern North America.

There has been increasing concern for Golden Eagle (Aquila chrysaetos) populations in North America due to current and future projections of mortality risk and habitat loss from anthropogenic sources....

Clinical Trials [650 Associated Clinical Trials listed on BioPortfolio]

Sorafenib-RT in Treating Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The incidence is highest in Asia and it is increasing in North America, with a two to three fold increase in mor...

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM

It has been almost 25 years since the publication of the pivotal trial results for the first disease-modifying therapy (DMT) for RRMS. Currently disease modifying therapies (DMTs) for MS a...

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

This trial will be conducted in Africa, Asia, North America and South America. The aim of this clinical trial is to compare NN1250 with sitagliptin, as add-on to subject's own current oral...

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

This trial was conducted in Europe, Middle East, North America and South America. The aim of this trial was to compare the use of an intensified insulin treatment Insulin Aspart (NovoRapi...

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

This trial is conducted in Europe, North America and South America. The aim of this trial is to investigate the clinical efficacy of NNC0109-0012, a human monoclonal antibody, compared to ...

Companies [1933 Associated Companies listed on BioPortfolio]

Trilantic North America

Trilantic Capital Management L.P. ("Trilantic North America") is a private equity firm focused on control and significant minority investments in North America. Trilantic North Am...

Trilantic Capital Partners

Trilantic Capital Partners is a private equity firm focused on control and significant minority investments in North America and Europe with primary investment focus in consumer, ...

Fagron North America

Fagron North America is a group of innovative, scientific pharmaceutical companies that focus on optimizing and innovating pharmaceutical compounding across the U.S. Fagron North ...

JMS North America Corporation

JMS North America (JMSNA) was established as a wholly owned subsidiary of JMS Co., Ltd., one of the largest Japanese medical device companies, in March 1993. Now JMSNA's headquarters is located in Hay...

Zurich

Zurich in North America is a part of Zurich Financial Services Group (Zurich), an insurance-based financial services provider with a global network of subsidiaries and offices in ...

More Information about "Trilantic North America" on BioPortfolio

We have published hundreds of Trilantic North America news stories on BioPortfolio along with dozens of Trilantic North America Clinical Trials and PubMed Articles about Trilantic North America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trilantic North America Companies in our database. You can also find out about relevant Trilantic North America Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record